| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-211-78741-0_5 |
| P698 | PubMed publication ID | 19368083 |
| P2093 | author name string | P Boon | |
| K Vonck | |||
| V De Herdt | |||
| P2860 | cites work | Neurochemical effects of vagus nerve stimulation in humans | Q28318384 |
| Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin | Q29615449 | ||
| The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala | Q30312117 | ||
| Feasibility of vagus nerve stimulation-synchronized blood oxygenation level-dependent functional MRI. | Q30482220 | ||
| Late onset bradyarrhythmia during vagus nerve stimulation | Q33154934 | ||
| Effects of vagus nerve stimulation on respiration during sleep: a pilot study | Q33926355 | ||
| Functional and chemical anatomy of the afferent vagal system | Q33934014 | ||
| Vagus nerve stimulation, side effects, and long-term safety | Q34101906 | ||
| Anatomy of human extrinsic cardiac nerves and ganglia | Q34196292 | ||
| Effects of vagus nerve stimulation on sleep-related breathing in epilepsy patients | Q34208313 | ||
| Predictors of laryngeal complications in patients implanted with the Cyberonics vagal nerve stimulator | Q34522204 | ||
| Vagus Nerve Stimulation in the Developmentally Disabled | Q35074466 | ||
| Vagus-nerve stimulation for the treatment of epilepsy | Q35172370 | ||
| Randomized controlled trials of epilepsy surgery | Q35200136 | ||
| Vagus nerve stimulation may protect GABAergic neurons following traumatic brain injury in rats: An immunocytochemical study | Q35844430 | ||
| Complete heart block with ventricular asystole during left vagus nerve stimulation for epilepsy | Q35893397 | ||
| Effects of vagus nerve stimulation in a patient with temporal lobe epilepsy and Asperger syndrome: case report and review of the literature | Q36735912 | ||
| Vagus nerve stimulation in children with refractory epilepsy: unusual complications and relationship to sleep-disordered breathing | Q36874252 | ||
| Vagus nerve stimulation in intractable childhood epilepsy: a Korean multicenter experience | Q37220520 | ||
| Developing a comprehensive presurgical functional MRI protocol for patients with intractable temporal lobe epilepsy: a pilot study | Q38432936 | ||
| The implantable neurocybernetic prosthesis system | Q67682985 | ||
| Sensory stimulation for inhibition of epileptic seizures | Q69182109 | ||
| Suppression of interictal spikes and seizures by stimulation of the vagus nerve | Q70492934 | ||
| Vagus nerve stimulation for complex partial seizures: surgical technique, safety, and efficacy | Q70519998 | ||
| Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve | Q70910954 | ||
| Vagus nerve stimulation for the treatment of medically intractable seizures. Results of a 1-year open-extension trial. Vagus Nerve Stimulation Study Group | Q71766959 | ||
| Vagus nerve stimulation induces a sustained anticonvulsant effect | Q71775968 | ||
| Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study Group | Q72048785 | ||
| The blood supply of vagus nerve in the human: its implication in carotid endarterectomy, thyroidectomy and carotid arch aneurectomy | Q72187766 | ||
| Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures | Q72348536 | ||
| A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group | Q72541815 | ||
| Effects of vagal nerve stimulation on laryngeal function | Q72735891 | ||
| Treatment of epilepsy by stimulation of the vagus nerve | Q72820871 | ||
| Vagus Nerve Stimulation for Patients in Residential Treatment Facilities | Q73061052 | ||
| Vagus nerve stimulation therapy for epilepsy in older adults | Q73556140 | ||
| Horner syndrome associated with implantation of a vagus nerve stimulator | Q73589311 | ||
| Vocal cord adduction during vagus nerve stimulation for treatment of epilepsy | Q73621858 | ||
| Chronic stimulation of the left vagus nerve: cognitive motor effects | Q73640245 | ||
| Single incision for implanting a vagal nerve stimulator system (VNSS): technical note | Q73745918 | ||
| Electrical stimulation of afferent vagus nerve induces IL-1beta expression in the brain and activates HPA axis | Q74008401 | ||
| Effects of vagus nerve stimulation on progressive myoclonus epilepsy of Unverricht-Lundborg type | Q74231746 | ||
| Aggravation of partial epilepsy and emergence of new seizure type during treatment with VNS | Q74333149 | ||
| Functional and histological studies of the vagus nerve and its branches to the heart, lungs and abdominal viscera in the cat | Q74393864 | ||
| Laryngeal and vocal changes during vagus nerve stimulation in epileptic patients | Q74546666 | ||
| Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial | Q74800943 | ||
| Aspiration: a potential complication to vagus nerve stimulation | Q77303391 | ||
| Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years | Q77360448 | ||
| MRI of the brain is safe in patients implanted with the vagus nerve stimulator | Q77366222 | ||
| Spasm of the sternocleidomastoid muscle induced by vagal nerve stimulation | Q77387985 | ||
| Cardiorespiratory variables and sensation during stimulation of the left vagus in patients with epilepsy | Q77416369 | ||
| Chronic stimulation of the left vagal nerve in children: effect on swallowing | Q77425187 | ||
| Stimulation of the phrenic nerve as a complication of vagus nerve pacing in a patient with epilepsy | Q77441683 | ||
| Chronic diarrhea associated with vagal nerve stimulation | Q77531772 | ||
| Revision and removal of stimulating electrodes following long-term therapy with the vagus nerve stimulator | Q77883141 | ||
| Staged approach to epilepsy management | Q77996094 | ||
| Effects of two different cycles of vagus nerve stimulation on interictal epileptiform discharges | Q79269488 | ||
| Vagus nerve stimulation for drug-resistant epilepsy in children and young adults. | Q51700125 | ||
| Persistent antiepileptic effects after vagus nerve stimulation ends? | Q51728308 | ||
| Vagus nerve stimulation in humans: neurophysiological studies and electrophysiological monitoring. | Q51742921 | ||
| Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome: clinical results, neuropsychological effects, and cost-effectiveness. | Q51962015 | ||
| Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: a rare complication of intraoperative device testing. | Q51980813 | ||
| Slow hyperpolarization in cortical neurons: a possible mechanism behind vagus nerve simulation therapy for refractory epilepsy? | Q52162891 | ||
| Intermittent vagal nerve stimulation in paediatric patients: 1-year follow-up. | Q53442687 | ||
| Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study. | Q53461923 | ||
| Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome. | Q53472676 | ||
| Vagal nerve stimulation in epileptic encephalopathies. | Q53555111 | ||
| Vagus nerve stimulation in 16 children with refractory epilepsy. | Q53571489 | ||
| The current status of neuroimaging for epilepsy: editorial review. | Q53656520 | ||
| Vagal nerve stimulation in tuberous sclerosis complex patients. | Q53885034 | ||
| Vagus nerve stimulation treatment for Lennox-Gastaut syndrome. | Q54039142 | ||
| Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 VNS Study Group. | Q54097583 | ||
| Airway effects of direct left-sided cervical vagal stimulation in patients with complex partial seizures. | Q54204270 | ||
| Inhibition of experimental seizures in canines by repetitive vagal stimulation | Q54258675 | ||
| Major Psychiatric Disorders Subsequent to Treating Epilepsy by Vagus Nerve Stimulation | Q57248516 | ||
| Ventricular asystole during vagus nerve stimulation for epilepsy in humans | Q57544529 | ||
| Vagus nerve stimulation in children with mitochondrial electron transport chain deficiencies | Q62868727 | ||
| Vagus nerve stimulation for refractory idiopathic generalised epilepsy | Q62868884 | ||
| In vivoalteration of Strata valve setting by vagus nerve stimulator-activating magnet | Q63386992 | ||
| Acute effects of high frequency vagal nerve stimulation on balance and cognitive motor performance in epilepsy: three case study reports. | Q64884306 | ||
| Cognitive motor function after electrical stimulation of the vagus nerve | Q67543952 | ||
| Vagal sensory receptors and their reflex effects | Q39922608 | ||
| Left vagal nerve stimulation in children with medically refractory epilepsy. The Pediatric VNS Study Group | Q40639448 | ||
| The effect of vagal nerve stimulation on voice | Q40665371 | ||
| Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota | Q40994345 | ||
| Electrostimulation effects of the vagus nerve on balance in epilepsy | Q41107387 | ||
| Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat | Q41782749 | ||
| Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group | Q42597973 | ||
| Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. | Q42613827 | ||
| Acute psychosis and EEG normalisation after vagus nerve stimulation | Q43071600 | ||
| Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results | Q43411258 | ||
| Epilepsy, vagal nerve stimulation by the NCP system, mortality, and sudden, unexpected, unexplained death | Q43816682 | ||
| An implantable neurocybernetic prosthesis system | Q43927575 | ||
| Efficacy and safety of vagus nerve stimulation in patients with complex partial seizures | Q44037316 | ||
| Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation | Q44233180 | ||
| Effects of chronic left vagal stimulation on visceral vagal function in man. | Q44336427 | ||
| Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy | Q44568826 | ||
| Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: use of a cuff electrode for stimulating and recording | Q44693480 | ||
| Effects of vagus nerve stimulation on cortical excitability in epileptic patients | Q44947252 | ||
| Vagus nerve stimulation therapy: 2-year prospective open-label study of 40 subjects with refractory epilepsy and low IQ who are living in long-term care facilities | Q45296495 | ||
| Surgical technique for implantation of the neurocybernetic prosthesis. | Q45905155 | ||
| Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures | Q46272251 | ||
| Control of refractory status epilepticus precipitated by anticonvulsant withdrawal using left vagal nerve stimulation: a case report | Q46623895 | ||
| Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. | Q46962887 | ||
| Self-inflicted vocal cord paralysis in patients with vagus nerve stimulators. Report of two cases | Q47302455 | ||
| Positioning of vagal nerve stimulators: technical note | Q47621456 | ||
| Vagus nerve stimulation induces concomitant respiratory alterations and a decrease in SaO2 in children. | Q47687054 | ||
| The effects of vagus nerve stimulation therapy on patients with intractable seizures and either Landau-Kleffner syndrome or autism | Q47855603 | ||
| Vagal nerve stimulation induces intermittent hypocapnia | Q48136257 | ||
| Vagus nerve prolonged stimulation in cats: effects on epileptogenesis (amygdala electrical kindling): behavioral and electrographic changes | Q48165281 | ||
| Is vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy? | Q48210822 | ||
| Presurgical evaluation of the motor hand area with functional MR imaging in patients with tumors and dysplastic lesions | Q48235091 | ||
| Brain-type natriuretic peptide release and seizure activity during vagal nerve stimulation | Q48275147 | ||
| No evidence for cognitive side effects after 6 months of vagus nerve stimulation in epilepsy patients | Q48378259 | ||
| VNS in patients with previous unsuccessful resective epilepsy surgery: antiepileptic and psychotropic effects | Q48390407 | ||
| Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation | Q48395270 | ||
| Cerebral activation during vagus nerve stimulation: a functional MR study | Q48435174 | ||
| Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects | Q48504194 | ||
| Autonomic response and Fos expression in the NTS following intermittent vagal stimulation: importance of pulse frequency | Q48530979 | ||
| Modifications of sleep EEG induced by chronic vagus nerve stimulation in patients affected by refractory epilepsy. | Q48598158 | ||
| fMRI in patients implanted with a vagal nerve stimulator. | Q48600455 | ||
| Sleep apnea and excessive daytime somnolence induced by vagal nerve stimulation | Q48614903 | ||
| Vagus nerve stimulation reduces daytime sleepiness in epilepsy patients | Q48683895 | ||
| Brain natriuretic peptide-like immunoreactive innervation of the cardiovascular and cerebrovascular systems in the rat. | Q48854636 | ||
| Vagal nerve stimulation for status epilepticus | Q48875291 | ||
| Vagal stimulation for control of complex partial seizures in medically refractory epileptic patients | Q48915254 | ||
| Programmed and magnet-induced vagus nerve stimulation for refractory epilepsy | Q49056063 | ||
| Vagus nerve stimulation for refractory epilepsy: a transatlantic experience | Q49129981 | ||
| Left vagal nerve stimulation in six patients with hypothalamic hamartomas | Q50312511 | ||
| Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by Vagal nerve stimulation. | Q50879617 | ||
| Cardiac responses of vagus nerve stimulation: intraoperative bradycardia and subsequent chronic stimulation. | Q50917001 | ||
| Intraoperative human vagus nerve compound action potentials. | Q51618819 | ||
| Vagal nerve stimulator pocket infections. | Q51648589 | ||
| Effect of vagus nerve stimulation on adults with pharmacoresistant generalized epilepsy syndromes. | Q51671669 | ||
| P304 | page(s) | 111-146 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Advances and Technical Standards in Neurosurgery | Q15758649 |
| P1476 | title | Vagal nerve stimulation--a 15-year survey of an established treatment modality in epilepsy surgery | |
| P478 | volume | 34 |
| Q34073789 | Adenosine dysfunction and adenosine kinase in epileptogenesis |
| Q38833748 | Critical review evaluating the pig as a model for human nutritional physiology |
| Q52579593 | Epilepsy and Neuromodulation-Randomized Controlled Trials. |
| Q30359011 | Innervation of the Human Cavum Conchae and Auditory Canal: Anatomical Basis for Transcutaneous Auricular Nerve Stimulation. |
| Q36352103 | Neurostimulation-past, present, and beyond |
| Q35648123 | Progress in cell grafting therapy for temporal lobe epilepsy |
| Q92236033 | Review: Impact of food, gut-brain signals and metabolic status on brain activity in the pig model: 10 years of nutrition research using in vivo brain imaging |
Search more.